# Fragrance Manufacturing, Inc. dbs FMI – FDA 483, Apr 24, 2026

Source: https://www.keypedia.com/records/483/fragrance-manufacturing-inc-dbs-fmi/604383d9-3a9e-4fa5-bc2d-84dfd4c20d6d

> FDA 483 for Fragrance Manufacturing, Inc. dbs FMI on April 24, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Fragrance Manufacturing, Inc. dbs FMI
- Inspection Date: 2026-04-24
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: Fragrance Manufacturing, Inc. in Allentown, PA, received two observations during an FDA inspection of its drug product manufacturing facility. The firm was cited for failing to conduct adequate ongoing stability testing to determine appropriate expiration dates for drug products. Additionally, deficiencies were noted in preventing contamination and mix-ups, including inadequate barriers and environmental controls in manufacturing and raw material sampling areas.

## Related Documents

- [483 - 2022-09-14](https://www.keypedia.com/records/483/fragrance-manufacturing-inc-dbs-fmi/f422ea9c-5a1d-4e0b-b556-d85e472098b5) — date: September 14, 2022
- [EIR - 2022-09-14](https://www.keypedia.com/records/eir/fragrance-manufacturing-inc-dbs-fmi/98446e6d-740d-4df1-bff0-f6554a4c84b0) — date: September 14, 2022

## Related Officers

- [Azeezat M. Lawal](https://www.keypedia.com/people/azeezat-m-lawal/6068345c-a8c8-438e-9b59-f7fc35370a59)

Company: https://www.keypedia.com/companies/fragrance-manufacturing-inc-dbs-fmi/928e81c4-65b1-4945-8649-bce04b698cfb

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8